Abstract:
Disclosed are various embodiments of a self healing andon system. One embodiment of the present disclosure includes a system comprising at least one server. The system further includes logic executed on the at least one server that retrieves a defect history associated with a vendor and at least one product from an inbound shipment from a memory. The at least one product is stocked in a materials handling facility, and the defect history is associated with a specified time period. The at least one server extracts at least one inventory defect from the defect history in a computer system and calculates an inventory defect rate. The at least one server imposes remedial measures if the inventory defect rate exceeds a specified threshold of the inventory defect rate.
Abstract:
A method for controlling delay in a Passive Optical Network (PON) is applicable when a Precision Timing Protocol (PTP) message is transmitted in a downlink direction. The method includes obtaining a buffer duration of the PTP message destined for an Optical Network Unit (ONU), storing the PTP message destined for the ONU, and sending the PTP message to the ONU when a duration for storing the PTP message reaches the buffer duration.
Abstract:
Embodiments of circuits and systems for a harmonic tuning network coupled with a radio frequency (RF) push-pull power amplifier to terminate both second- and third-harmonic energies are disclosed. Other embodiments may also be described and claimed.
Abstract:
The present invention relates to optionally substituted 3-amino-4,5-dihydro-(1H or 2H)-pyrazolo[3,4-d]pyrimidin-6(7H)-ones and their 4-imino or 4-thioxo derivatives, e.g., 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo[3,4-d]pyrimidin-6(7H)-ones, 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo[3,4-d]pyrimidin-6(7H)-ones, 3-amino-4-(thioxo or imino)-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6(7H)-ones, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Abstract:
The present invention discloses a method and system for transferring TDM services in GPON, the method includes the steps of: in the case of performing the GPON ranging process, buffering the uplink TDM service data received by an optical signal transceiver in an Input Buffer, reading out and transferring the uplink TDM service data buffered in an Output Buffer. The present invention eliminates the possible interruption of TDM services during the GPON ranging process by buffering the uplink services at the OLT and ONU/ONT side and relevant processes, and therefore realizes the TDM service transmission without any loss during the GPON system ranging process.
Abstract:
A correlation-based rate adaptation scheme (CORA) is enabled for practical communication devices that provides for communication data rate adaptation in a complex and/or rapidly changing communication environment. Correlations may be determined between adjustable parameters of a communication scheme and one or more performance metrics and/or communication scheme operating regimes. In the context of the correlation-based rate adaptation scheme, adjustable parameters of the communication scheme may be considered as defining a multi-dimensional parameter space, and the determined correlations may be considered as correlation maps that may be used to guide parameter selection and adjustment. The use of correlation maps enables extraction of information from imperfect and/or incomplete measurements, and the information collected in the correlation maps may be used to tune corresponding communication scheme parameters to enhance communication performance.
Abstract:
Techniques for utilizing APs and messaging service for delivering personalized message to individual mobile devices connected to internet through APs.
Abstract:
Optionally substituted 4,5,7,8-tetrahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-2H-imidazo[1,2-a]pyrrolo[3,4-e]pyrimidine or 4,5,7,8,9-pentahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-2H-pyrimido[1,2-a]pyrrolo[3,4-e]pyrimidine compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising the same.
Abstract:
A light source mode alignment device and method and a passive optical network system are provided. The device includes a laser and a temperature control unit connected to each other and further includes a signal processing unit. The laser converts an incident light into a current signal. The current signal is amplified and converted into a voltage signal via a transimpedance amplifier. Together with a modulation signal generated by the signal processing unit, the voltage signal adjusts a bias voltage of the temperature control unit.
Abstract:
Raman spectra of protein immunoblots or enzyme linked immunosorbant assay procedures are acquired with a scanning Raman spectrometer. The sensitivity of the measurement is increased by conjugating secondary antibodies used in the Western blot and ELISA methods to surface enhanced Raman Scattering (SERS) labels. The resulting blot or well plate is analyzed with a Raman system that has forms a pixel map of the sample. More specifically, the Raman system generates an effectively line-shaped illumination pattern and scans the sample in the direction perpendicular to the line while the signal is accumulating on the detector. Each pixel is therefore a rectangle defined by the length of the illumination and the distance traveled by the sample within the duration of signal accumulation on the detector. The pixels are sequentially acquired to generate a map of the sample.